Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common sense.
about
Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common sense.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Oral antiviral therapy reduces ...... ing evidence and common sense.
@en
Oral antiviral therapy reduces ...... ing evidence and common sense.
@nl
type
label
Oral antiviral therapy reduces ...... ing evidence and common sense.
@en
Oral antiviral therapy reduces ...... ing evidence and common sense.
@nl
prefLabel
Oral antiviral therapy reduces ...... ing evidence and common sense.
@en
Oral antiviral therapy reduces ...... ing evidence and common sense.
@nl
P2093
P2860
P1476
Oral antiviral therapy reduces ...... ing evidence and common sense.
@en
P2093
Jidong Jia
Yuanyuan Kong
P2860
P2888
P304
P356
10.1007/S12072-016-9714-9
P577
2016-02-23T00:00:00Z